BIOMAT Database Logo BIOMAT Database Logo

[Selection of direct-acting antiviral agents for chronic hepatitis C infection]. 2018

Y J He, and Z H Liu, and J L Hou
Institute of Hepatology, Southern Medical University, Guangzhou 510515, China.

The elimination of hepatitis C virus(HCV) infection is still a long way to go. Direct-acting antiviral agents (DAAs) can make HCV completely cured by targeting various stages of its replication life cycle and meanwhile standardize and simplify the treatment. However, those relative factors may affect efficacy and safety should be considered by specialties in choosing the suitable regimens. Therefore, this article reviews various aspects of DAAs including development history, factors correlated with efficacy and safety, therapeutic regimens domestic listed and approved.

UI MeSH Term Description Entries
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D019698 Hepatitis C, Chronic INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. Chronic Hepatitis C

Related Publications

Y J He, and Z H Liu, and J L Hou
Direct-acting antiviral agents for hepatitis C virus infection.
January 2013, Annual review of pharmacology and toxicology,
Y J He, and Z H Liu, and J L Hou
Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection.
March 2014, Journal of clinical and translational hepatology,
Y J He, and Z H Liu, and J L Hou
[Direct-acting antiviral treatment of chronic hepatitis C infection].
April 2015, MMW Fortschritte der Medizin,
Y J He, and Z H Liu, and J L Hou
Direct-acting antiviral medications for chronic hepatitis C virus infection.
March 2011, Gastroenterology & hepatology,
Y J He, and Z H Liu, and J L Hou
Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.
September 2013, Expert opinion on investigational drugs,
Y J He, and Z H Liu, and J L Hou
The Impact of Direct-Acting Antiviral Agents on Cytomegalovirus Reactivation in Chronic Hepatitis C Infection.
April 2022, Asian Pacific journal of cancer prevention : APJCP,
Y J He, and Z H Liu, and J L Hou
Real-world experiences with direct-acting antiviral agents for chronic hepatitis C treatment.
February 2020, Journal of viral hepatitis,
Y J He, and Z H Liu, and J L Hou
Roadblocks to Accessing Direct-Acting Antiviral Agents for Treatment of Hepatitis C Virus Infection.
May 2015, Gastroenterology & hepatology,
Y J He, and Z H Liu, and J L Hou
New Direct-Acting Antiviral Therapies for Treatment of Chronic Hepatitis C Virus Infection.
July 2015, Gastroenterology & hepatology,
Y J He, and Z H Liu, and J L Hou
[New direct-acting antiviral agents for the treatment of chronic hepatitis C in 2014].
April 2014, Der Internist,
Copied contents to your clipboard!